Graeme Moyle, MD

Director of HIV Research Strategy
Chelsea & Westminster Hospital

Disclosure: Theratechnologies (Consultant)

Presentation(s):

• LB-7 - Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

  Saturday, October 24, 2020
  10:50am – 11:00am EDT